Company intelligence / Profile preview

Beijing Qi Jie Yuan Medicine Technology Development

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Beijing Qi Jie Yuan Medicine Technology Development is a biopharmaceutical company based in Beijing, China, specializing in the discovery and development of small molecule drugs for metabolic diseases. The company primarily focuses on G protein-coupled receptor (GPCR) targets to address unmet needs in type 2 diabetes mellitus. Its lead candidate, QJY-S001, is a GPR119 agonist currently undergoing clinical evaluation. Qi Jie Yuan's research strategy emphasizes the development of high-potency compounds with improved safety profiles compared to existing therapies. The firm operates as a private R&D entity within the Beijing Economic-Technological Development Area.

Therapeutic areas: Endocrinology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Beijing Qi Jie Yuan Medicine Technology Development.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Qi Jie Yuan Medicine Technology Development.

Explore the full profile